Outlook Therapeutics, Inc.
(NASDAQ : OTLK)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-1.25%194.261.3%$534.90m
GILDGilead Sciences, Inc.
-0.38%65.920.9%$358.67m
ALXNAlexion Pharmaceuticals, Inc.
-4.94%102.502.0%$309.45m
ILMNIllumina, Inc.
1.15%301.703.5%$306.72m
BIIBBiogen Inc.
-1.42%235.311.3%$295.44m
CELGCelgene Corporation
0.12%98.721.3%$288.72m
SRPTSarepta Therapeutics, Inc.
-2.38%82.8614.6%$174.60m
AAgilent Technologies, Inc.
0.58%76.841.6%$174.34m
VRTXVertex Pharmaceuticals Incorporated
-0.85%174.501.9%$173.05m
REGNRegeneron Pharmaceuticals, Inc.
-2.09%282.092.6%$168.99m
EXASExact Sciences Corporation
-1.77%104.9824.1%$132.80m
ACADACADIA Pharmaceuticals Inc.
-3.78%40.9913.9%$110.63m
INCYIncyte Corporation
-1.39%78.002.5%$84.52m
BMRNBioMarin Pharmaceutical Inc.
0.65%75.494.3%$71.69m
ALDRAlder Biopharmaceuticals, Inc.
0.43%18.7810.2%$64.21m

Company Profile

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.